Reckitt Benckiser (Australia) Pty Ltd v GlaxoSmithKline Australia Pty Ltd

Reckitt Benckiser (Australia) Pty Ltd took legal action against GlaxoSmithKline Australia Pty Ltd in the Federal Court of Australia. The dispute concerned the comparative advertising of pain relief products for treating common headaches, including tension-type headaches. Reckitt Benckiser alleged that the advertising by GlaxoSmithKline was misleading or deceptive, or likely to mislead or deceive, and that it made false representations.

The legal issues before the court were whether the advertising conducted by GlaxoSmithKline was indeed misleading or deceptive, or likely to mislead or deceive, and if it made any false representations. The court had to consider the advertising's accuracy, the context in which it was presented, and whether it could reasonably lead consumers to form a particular belief or impression about the advertised products.

In delivering the judgment, the court examined the content and context of the advertising in question. It assessed whether the claims made in the advertisements were supported by evidence and whether they could be interpreted in a misleading manner by consumers. The court determined that the advertising did not contain any misleading or deceptive statements or false representations. It found that the claims made were substantiated and that the context of the advertising did not lead to a misleading interpretation by consumers. Consequently, the appeal by Reckitt Benckiser was dismissed.

The court also granted leave to the parties to file submissions on costs to be determined on the papers, in accordance with Rule 39.32 of the Federal Court Rules 2011.